<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04581304</url>
  </required_header>
  <id_info>
    <org_study_id>0136-20-RMB CTIL</org_study_id>
    <nct_id>NCT04581304</nct_id>
  </id_info>
  <brief_title>The Use of Bio-Oss Collagen for Sinus Augmentation Using the Transcrestal Approach.</brief_title>
  <official_title>The Use of Bio-Oss Collagen for Sinus Augmentation Using the Transcrestal Approach.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rambam Health Care Campus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rambam Health Care Campus</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To assess vertical bone height gain with Geistlich Bio-Oss Collagen used in conjunction with&#xD;
      simultaneous implant installation in transcrestal approach sinus augmentation.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      One of the most common situations in the posterior maxilla is reduced alveolar bone height as&#xD;
      a result of tooth extraction and the following bone remodeling process, and maxillary sinus&#xD;
      pneumatization. Lack of alveolar bone volume may compromise dental implant installation.&#xD;
      Maxillary sinus augmentation is considered a very predictable solution for implant&#xD;
      installation in limited amount of bone in the posterior maxilla. In general, there are two&#xD;
      main maxillary sinus augmentation methods: the lateral approach and the transcrestal. In both&#xD;
      methods, the idea is to expend the alveolar ridge in vertical direction on the expense of the&#xD;
      maxillary sinus. Sinus augmentation using the transcrestal approach is a well known procedure&#xD;
      which is being use for over 40 years. As time goes by, implant dentistry is evolving and&#xD;
      improving, there is a constant progress in this field including new bone substitutes&#xD;
      materials.&#xD;
&#xD;
      Geistlich Bio-Oss® Collagen - can improve the results obtained by sinus augmentation using&#xD;
      the transcrestal approach, by better ease of use for the operator which makes it easier for&#xD;
      the operator and the patient.&#xD;
&#xD;
      Study hypothesis: The vertical bone height gained by using Geistlich Bio-Oss Collagen in&#xD;
      transcrestal approach sinus augmentation will be comparable to using Bio-Oss Collagen, with&#xD;
      greater operator satisfaction and less intra-operative complications.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 16, 2020</start_date>
  <completion_date type="Anticipated">February 16, 2024</completion_date>
  <primary_completion_date type="Anticipated">September 16, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Vertical bone height. (mm) Changes in vertical bone height after transcrestal approach sinus augmentation.</measure>
    <time_frame>Pre op; immediately post-op and at 6 months.</time_frame>
    <description>Measuring the changes in vertical bone height after transcrestal approach sinus augmentation.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The success rate of osseointegrated implants. (%)</measure>
    <time_frame>At 6 months after intervention.</time_frame>
    <description>The percentage of osseointegrated implants that were installed with simultaneous transcrestal approach sinus augmentation.- using Bio-Oss collagen®.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Procedure time measurement. (min)</measure>
    <time_frame>The procedure time measurement will start after flaps are elevated at pilot drilling (2.4mm diameter). and it will be stopped when the implant was inserted and insertion torque was assessed.</time_frame>
    <description>To evaluate the time needed for transcrestal approach sinus augmentation using Bio-Oss collagen® and in the conventional way, using Bio-Oss granules.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patients and operator satisfaction. (1-10 ruler scale)</measure>
    <time_frame>At the suture removal visit - 14 days after procedure.</time_frame>
    <description>To study operator and patients satisfaction using the 2 materials. They will be assessed by giving the patients questionnaires and satisfaction ruler using a 1-10 ruler scale.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications</measure>
    <time_frame>During the procedure, During the follow up - 14 days, 6 months after intervention.</time_frame>
    <description>Explore intra and post operative complications.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Bone Loss</condition>
  <condition>Missing Teeth</condition>
  <arm_group>
    <arm_group_label>Bio-Oss Collagen</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Transcrestal approach sinus augmentation using Geistlich Bio-Oss Collagen®.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Bio-Oss Granules</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Transcrestal approach sinus augmentation using Geistlich Bio-Oss®.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Geistlich Bio-Oss® Collagen</intervention_name>
    <description>Geistlich Bio-Oss® Collagen is intended to be used for filling bone defects and for bone augmentation.</description>
    <arm_group_label>Bio-Oss Collagen</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Geistlich Bio-Oss® Granules</intervention_name>
    <description>Geistlich Bio-Oss® Granules is intended to be used for filling bone defects and for bone augmentation.</description>
    <arm_group_label>Bio-Oss Granules</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients above the age of 18.&#xD;
&#xD;
          -  Patients with edentulous ridge maximal height of 8mm≥ beneath the maxillary sinus.&#xD;
&#xD;
          -  Patients with edentulous ridge minimal height of 3mm≤ beneath the maxillary sinus.&#xD;
&#xD;
          -  Patients who need single implant placement at the posterior maxilla.&#xD;
&#xD;
          -  Signed, well filled and dated informed consent form.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Inability to complete or understand the informed consent process.&#xD;
&#xD;
          -  Pregnant women.&#xD;
&#xD;
          -  Lactating women.&#xD;
&#xD;
          -  Patients who use medications that affect bone metabolism such as IV bisphosphonates.&#xD;
&#xD;
          -  Heavy smokers.&#xD;
&#xD;
          -  Patients with chronic/acute sinus infections&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eli Machtei, DMD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rambam Health Care Campus</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Eli Machtei, DMD</last_name>
    <phone>9727772983</phone>
    <email>machtei@rambam.health.gov.il</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Eran Gabay, DMD</last_name>
    <phone>9727772983</phone>
    <email>eran.gabay@mail.huji.ac.il</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Rambam Health Care Campus, Dept. of Periodontology</name>
      <address>
        <city>Haifa</city>
        <zip>31096</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>October 4, 2020</study_first_submitted>
  <study_first_submitted_qc>October 4, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 9, 2020</study_first_posted>
  <last_update_submitted>October 4, 2020</last_update_submitted>
  <last_update_submitted_qc>October 4, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rambam Health Care Campus</investigator_affiliation>
    <investigator_full_name>machtei</investigator_full_name>
    <investigator_title>Rambam Health Care Campus</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tooth Loss</mesh_term>
    <mesh_term>Anodontia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

